Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 3/2003

01-06-2003 | Original Article

Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome

Authors: Rui Medeiros, Deolinda Pereira, Noémia Afonso, Carlos Palmeira, Cristina Faleiro, Carlos Afonso-Lopes, Margarida Freitas-Silva, André Vasconcelos, Sandra Costa, Teresa Osório, Carlos Lopes

Published in: International Journal of Clinical Oncology | Issue 3/2003

Login to get access
Metadata
Title
Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome
Authors
Rui Medeiros
Deolinda Pereira
Noémia Afonso
Carlos Palmeira
Cristina Faleiro
Carlos Afonso-Lopes
Margarida Freitas-Silva
André Vasconcelos
Sandra Costa
Teresa Osório
Carlos Lopes
Publication date
01-06-2003
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 3/2003
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-003-0318-8

Other articles of this Issue 3/2003

International Journal of Clinical Oncology 3/2003 Go to the issue

Case Report

A successful case of oral molecularly targeted therapy with imatinib for peritoneal metastasis of a gastrointestinal stromal tumor

ORIGINAL ARTICLE

Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer

ORIGINAL ARTICLE

Bacillus Calmette–Guerin-refractory superficial bladder cancers: focus on pretreatment episodes

REVIEW ARTICLE

5-Fluorouracil and dihydropyrimidine dehydrogenase

Review Article

The place of lymphatic mapping and sentinel node biopsy in oncology

Original Article

Radiation therapy for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits